1-2 of 2
Hiroko Nishida, MD., PhD.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD26 Is a Novel Target for the Treatment of Tumor Progression and Its Related Osteolytic Bone Disease in Multiple Myeloma

Hiroko Nishida, MD, PhD, Hiroko Madokoro, Hiroshi Suzuki, Mutsumi Hayashi, MD, PhD, Chikao Morimoto, MD, PhD, Michiie Sakamoto, MD, PhD, Taketo Yamada, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 1809.
https://doi.org/10.1182/blood.V126.23.1809.1809
Published: 2015
Journal Articles

Targeting CD26 with Humanized Monoclonal Antibody, As a Novel Approach to Inhibit Human Osteoclast Differentiation and Subsequent Bone Resorption

Hiroko Nishida, MD., PhD., Hiroko Madokoro, Hiroshi Suzuki, Michiie Sakamoto, M.D., Ph.D., Chikao Morimoto, M.D., Ph.D., Taketo Yamada, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1348.
https://doi.org/10.1182/blood.V120.21.1348.1348
Published: 2012